Alzheimer's disease is characterized by progressive dementia, cortical
atrophy with synaptic loss, and the accumulation of neurofibrillary t
angles and senile plaques containing beta-amyloid. The beta-amyloid pr
otein precursor (beta-APP), may normally be involved in cell adhesion
related to synaptic maintenance. Loss of synapses correlates with deme
ntia, suggesting that synaptic deficits may underlie the disease. Syna
pse stability may depend on the action of tissue transglutaminase (tTG
), an enzyme capable of crosslinking large, multi-domain extracellular
glycoproteins, that is active and present at synapses. We now show th
at beta-APP is a substrate for tTG in vitro that results in dimers and
multimers by silver staining and immunoblotting. This novel post-tran
slational modification suggests further roles for beta-APP in synaptic
function as well as in Alzheimer's disease.